Detection of Cell Wall Galactomannoprotein Afmp1p in Culture Supernatants of Aspergillus fumigatus and in Sera of Aspergillosis Patients

ABSTRACT Mannoproteins are important and abundant structural components of fungal cell walls. The AFMP1 gene encodes a cell wall galactomannoprotein of Aspergillus fumigatus. In the present study, we show that Afmp1p is secreted into the cell culture supernatant at a level that can be detected by Western blotting. A sensitive enzyme-linked immunosorbent assay (ELISA) developed with antibodies against Afmp1p was capable of detecting this protein from the cell culture supernatant of A. fumigatus. The anti-Afmp1p antibody is specific since it fails to react with any protein from lysates of Aspergillus flavus, Aspergillus niger, Aspergillus terreus, Penicillium marneffei, Candida albicans, Cryptococcus neoformans, Blastomyces dermatitidis, and Histoplasma capsulatum by Western blotting. In addition, this Afmp1p antigen-based ELISA is also specific for A. fumigatus since the cell culture supernatants of the other eight fungi gave negative results. Finally, a clinical evaluation of sera from invasive aspergillosis patients indicates that 8 of 15 (53%) patients are Afmp1p antigen test positive. Furthermore, an Afmp1p antibody test was performed with these serum specimens. The combined antibody and antigen tests for invasive aspergillosis carry a sensitivity of 86.7% (13 of 15). The specificities of the tests are high since none of the 138 control sera, including 100 from normal blood donors, 20 from patients with penicilliosis marneffei, 6 from patients with candidemia, 8 from patients with typhoid fever, and 4 from patients with melioidosis, was positive by either test. In conclusion, the combined Afmp1p antibody and antigen tests are highly sensitive and specific for A. fumigatus invasive aspergillosis.

[1]  L. Tissi,et al.  Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. , 1988, Journal of general microbiology.

[2]  K. Yuen,et al.  Characterization of AFMP1: a Novel Target for Serodiagnosis of Aspergillosis , 2001, Journal of Clinical Microbiology.

[3]  K. Yuen,et al.  Detection of Antibodies Specific to an Antigenic Cell Wall Galactomannoprotein for Serodiagnosis of Aspergillus fumigatus Aspergillosis , 2002, Journal of Clinical Microbiology.

[4]  A. Mencacci,et al.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice , 1994, Infection and immunity.

[5]  K. Yuen,et al.  Detection of Cell Wall Mannoprotein Mp1p in Culture Supernatants of Penicillium marneffei and in Sera of Penicilliosis Patients , 1999, Journal of Clinical Microbiology.

[6]  K. Yuen,et al.  Detection of Specific Antibodies to an Antigenic Mannoprotein for Diagnosis of Penicillium marneffeiPenicilliosis , 1998, Journal of Clinical Microbiology.

[7]  F. Urbani,et al.  Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans. , 1993, The Journal of infectious diseases.

[8]  A. Casadevall,et al.  Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages , 1995, Infection and immunity.

[9]  Yongmoon Han,et al.  Antibody response that protects against disseminated candidiasis , 1995, Infection and immunity.

[10]  J. Latgé,et al.  Aspergillus fumigatus and Aspergillosis , 1999, Clinical Microbiology Reviews.

[11]  G. Verhoef,et al.  Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis , 1999, Journal of Clinical Microbiology.

[12]  J. Djeu,et al.  Identification of a mannoprotein fraction from Candida albicans that enhances human polymorphonuclear leukocyte (PMNL) functions and stimulates lactoferrin in PMNL inhibition of candidal growth. , 1992, The Journal of infectious diseases.

[13]  K. Yuen,et al.  Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  K. Wong,et al.  Differences in Clinical and Laboratory Diagnostic Characteristics of Penicilliosis Marneffei in Human Immunodeficiency Virus (HIV)- and Non-HIV-Infected Patients , 2001, Journal of Clinical Microbiology.

[15]  A. Casadevall,et al.  Antibody immunity and invasive fungal infections , 1995, Infection and immunity.

[16]  K. Yuen,et al.  DNA immunization using a secreted cell wall antigen Mp1p is protective against Penicillium marneffei infection. , 2002, Vaccine.

[17]  D. Denning,et al.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. , 1990, Reviews of infectious diseases.

[18]  M. Puliti,et al.  In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. , 1991, Cellular immunology.

[19]  K. Yuen,et al.  MP1 Encodes an Abundant and Highly Antigenic Cell Wall Mannoprotein in the Pathogenic Fungus Penicillium marneffei , 1998, Infection and Immunity.